interesting post @Rykster. Maybe you should get in touch with Fidelity and share some of your "research" with them. I'm sure they would welcome it seeing they have substantial skin in the game now.
I'm all for an objective view on stocks however your post seems to be more opinionated than researched based. easy to slag a company out when the price tanks. however, if comparing RCE compounds with methylated sprits is the extent of your research then maybe go back to the drawing board and read some previous announcements. you're correct in saying RCE compounds are yet to be proven in clinical trials.. but the market cap will reflect that in its price when RCE hit those milestones.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)